Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.09, $0.17 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $51 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.